313 related articles for article (PubMed ID: 16877909)
1. Results of botulinum toxin: an application to blepharospasm Schwartz-Jampel syndrome.
Vargel I; Canter HI; Topaloglu H; Erk Y
J Craniofac Surg; 2006 Jul; 17(4):656-60. PubMed ID: 16877909
[TBL] [Abstract][Full Text] [Related]
2. Orbicularis myectomy with levator advancement in Schwartz-Jampel syndrome.
Lucci LM; Yen MT; Anderson RL; Hwang IP; Black RE
Am J Ophthalmol; 2001 Nov; 132(5):799-801. PubMed ID: 11704053
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Blepharospasm in Schwartz-Jampel Syndrome: Botulinum Toxin A Injection or Surgery.
Kashkouli MB; Shahrzad S; Jazayeri AA; Abtahi MB
Ophthalmic Plast Reconstr Surg; 2017; 33(3S Suppl 1):S47-S49. PubMed ID: 26020714
[TBL] [Abstract][Full Text] [Related]
4. Schwartz-Jampel syndrome: surgical management of the myotonia-induced blepharospasm and acquired ptosis after failure with botulinum toxin A injections.
Morrison DA; Mellington FB; Hamada S; Moore AT
Ophthalmic Plast Reconstr Surg; 2006; 22(1):57-9. PubMed ID: 16418670
[TBL] [Abstract][Full Text] [Related]
5. Orbicularis Oculi Myectomy as a Treatment for Blepharospasm in a Case of Schwartz Jampel Syndrome.
Eshraghi B; Shadravan M; Aalami E; Pour EK
J Ophthalmic Vis Res; 2016; 11(3):329-32. PubMed ID: 27621795
[TBL] [Abstract][Full Text] [Related]
6. Management of blepharospasm and blepharophimosis associated with Schwartz-Jampel syndrome.
Ding J; Xu Y; Yuan B; Li D
J AAPOS; 2021 Feb; 25(1):54-56. PubMed ID: 33601038
[TBL] [Abstract][Full Text] [Related]
7. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
Cakmur R; Ozturk V; Uzunel F; Donmez B; Idiman F
J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type A in the treatment of facial myotonia in Schwartz-Jampel syndrome.
Bandeira ID; Jagersbacher JG; Barretto TL; Santos CV; Lucena R
Muscle Nerve; 2017 Aug; 56(2):E10-E11. PubMed ID: 28187499
[No Abstract] [Full Text] [Related]
9. Effects of Repeated Eyelid Injections with Botulinum Toxin A on Innervation of Treated Muscles in Patients with Blepharospasm.
Olson RM; Mokhtarzadeh A; McLoon LK; Harrison AR
Curr Eye Res; 2019 Mar; 44(3):257-263. PubMed ID: 30380945
[TBL] [Abstract][Full Text] [Related]
10. Botulinum A toxin (BOTOX) in the lower eyelid: dose-finding study.
Flynn TC; Carruthers JA; Carruthers JA; Clark RE
Dermatol Surg; 2003 Sep; 29(9):943-50; discussion 950-1. PubMed ID: 12930337
[TBL] [Abstract][Full Text] [Related]
11. Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasm.
Conte A; Fabbrini G; Belvisi D; Marsili L; Di Stasio F; Berardelli A
Eur J Neurol; 2010 Mar; 17(3):449-55. PubMed ID: 19968711
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of focal dystonia with botulinum toxin A].
Sojer M; Wissel J; Müller J; Poewe W
Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
[TBL] [Abstract][Full Text] [Related]
13. Levator aponeurosis surgery in Schwartz-Jampel syndrome.
Cruz AA; Souza CA; Plastino Júnior LS
Ophthalmic Plast Reconstr Surg; 1998 Jul; 14(4):271-6. PubMed ID: 9700736
[TBL] [Abstract][Full Text] [Related]
14. Dilution, storage, and electromyographic guidance in the use of botulinum toxins.
Mantell AM
Dermatol Clin; 2004 Apr; 22(2):135-6, v. PubMed ID: 15222572
[TBL] [Abstract][Full Text] [Related]
15. Effect of upper eyelid myectomy on subsequent chemodenervation in the management of benign essential blepharospasm.
Kent TL; Petris CK; Holds JB
Ophthalmic Plast Reconstr Surg; 2015; 31(3):222-6. PubMed ID: 25192329
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
Bhidayasiri R; Cardoso F; Truong DD
Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
[TBL] [Abstract][Full Text] [Related]
17. Effect of Botulinum Toxin A Treatment on Eyelid Pressure in Eyes with Blepharospasm.
Namiguchi K; Mizoue S; Ohta K; Shiraishi A
Curr Eye Res; 2018 Jul; 43(7):896-901. PubMed ID: 29641935
[TBL] [Abstract][Full Text] [Related]
18. Keratoconus progression is not inhibited by reducing eyelid muscular force with botulinum toxin A treatment: a randomized trial.
Renesto ADC; Osaki TH; Osaki MH; Hirai FE; Campos M
Arq Bras Oftalmol; 2017; 80(2):88-92. PubMed ID: 28591280
[TBL] [Abstract][Full Text] [Related]
19. Disabling muscle of Riolan: A novel concept of orbicularis oculi myectomy for refractory benign essential blepharospasm.
Takahashi Y; Vaidya A; Lee PAL; Kono S; Kakizaki H
Eur J Ophthalmol; 2021 Nov; 31(6):3411-3417. PubMed ID: 33579161
[TBL] [Abstract][Full Text] [Related]
20. Is it always necessary to apply botulinum toxin into the lower facial muscles in hemifacial spasm?: a randomized, single-blind, crossover trial.
Colakoglu BD; Cakmur R; Uzunel F
Eur Neurol; 2011; 65(5):286-90. PubMed ID: 21502764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
